spacer
home > epc > spring 2018 > early beginnings
PUBLICATIONS
European Pharmaceutical Contractor

Early Beginnings

Moving a promising drug candidate from the laboratory to first-in-human (FIH) trials is a complex, multistage challenge. Coordinating the formulation development steps, manufacturing, and logistics involved requires careful management and planning.

Integrating the process in collaboration with expert vendors offers drug developers an efficient, cost-effective pathway to success in early phase development. Furthermore, experienced contractors can help drug companies avoid the early phase pitfalls that can see projects fail at a later stage.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
1
     

There are no comments in regards to this article.

spacer
Dr Torkel Gren is General Manager at Recipharm Pharmaceutical Development. Torkel holds degrees in pharmacy and business administration, as well a PhD in Pharmaceutics from Uppsala University, Sweden. He has worked in the pharma industry since 1988 and has held a number of scientist and manager positions in Europe and the US. Torkel was lead formulator and co-inventor of Detrol OD/Detrusitol SR. He is a member of the board of the Swedish Pharmaceutical Society.

Anders Millerhovf is CEO at CTC Clinical Trial Consultants. He holds a degree in medical biology from Linköping University, Sweden. Anders has worked in the life sciences industry since 2002 and has been focused on Phase 0-2a projects in various management and director positions. He has been a partner at CTC since 2012.
spacer
Dr Torkel Gren
spacer
spacer
spacer
Anders Millerhovf
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Zenith Technologies win Cork Company of the Year

We’re very proud to announce that last Friday we won the Cork Company of the Year Award in the corporate category.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 
Industry Events

10th Annual Summit for Clinical Ops Executives

18-21 February 2019, Hyatt Regency Orlando, Florida

Celebrating its 10th successful year, SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 19 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including...
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement